Second-Trimester Maternal Serum Invasive Trophoblast Antigen: A Marker for Down Syndrome Screening
- 1 August 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (8) , 1433-1435
- https://doi.org/10.1373/clinchem.2004.032839
Abstract
Background: Increased homocysteine has been associated with pregnancy complications.Keywords
This publication has 10 references indexed in Scilit:
- Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen)Clinical Chemistry, 2003
- Elevated maternal urine level of β-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of Down syndromeAmerican Journal of Obstetrics and Gynecology, 1999
- Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second TrimestersNew England Journal of Medicine, 1999
- Serum hyperglycosylated hCG: a potential screening test for fetal Down syndromePrenatal Diagnosis, 1999
- Second trimester screening for Down's syndrome using maternal serum dimeric inhibin AJournal of Medical Screening, 1998
- hCG and the free β-subunit as screening tests for Down syndromePrenatal Diagnosis, 1998
- Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndromePrenatal Diagnosis, 1997
- Maternal serum screening for Down syndrome in the United States: A 1995 surveyAmerican Journal of Obstetrics and Gynecology, 1997
- PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKERPrenatal Diagnosis, 1996
- Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancyFertility and Sterility, 1982